In the study, treatment of HDAC6i 23BB at a dose of 40 mg/kg/d for 3 days effectively alleviated cisplatin-induced AKI and significantly suppressed tubular epithelial cell HDAC6 activity by the up-regulation of acetyl histone H3 in the injured kidney tissues. Here, HDAC6 is linked to acute kidney injury.